| Agent Name |
Daunomycin |
|---|
| CAS Number |
20830-81-3 |
|---|
| Formula |
C27-H29-N-O10 |
|---|
| Major Category |
Other Uses |
|---|
| Synonyms |
(+)-Daunomycin; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; Acetyladriamycin; Cerubidin; Daunamycin; Daunarubicinum; DaunoXome; Daunomycin; Daunorrubicina; Daunorubicin; Daunorubicine; Daunorubicinum [INN-Latin]; FI6339; Leukaemomycin C; Rubidomycin; Rubomycin C; [ChemIDplus] |
|---|
| Category |
Pharmaceuticals |
|---|
| Description |
Thin, red needles; [HSDB] |
|---|
| Sources/Uses |
An anti-mitotic agent used in cancer chemotherapy; [HSDB] |
|---|
| Comments |
Daunomycin is a bone marrow suppressant. About 2% of treated patients develop cardiotoxicity. [HSDB] |
|---|
| Exposure Assessment |
|---|
| Vapor Pressure |
3.46 x 10 -22 mm Hg |
|---|
| Links to Other NLM Databases |
|---|
| Health Studies |
Human Health Effects from Hazardous Substances Data Bank: DAUNORUBICIN
|
|---|
|
|
